GL1X · GenesisL1 explorer

Research workbench

Catalytic domain of the antimicrobial peptidase lysostaphin from staphylococcus simulans crystallized in the presence of phosphate

Analyse Catalytic domain of the antimicrobial peptidase lysostaphin from staphylococcus… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4QP5
Type
protein
Length
267 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Lysostaphin
EC
3.4.24.75
UniProt
P10547
Ligands
ZN, PO4
Pockets
2 · best druggability 0.60

Structure

x-ray diffraction · 2 distinct chains · 9% helix, 42% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALysostaphin (EC 3.4.24.75)protein13410% helix, 41% strandP10547
BLysostaphin (EC 3.4.24.75)protein1339% helix, 44% strandP10547

Ligands and binding sites

  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • PO4 · Phosphate ion · ion · 2 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11520.600.8327PO4, GOL
21790.570.8130PO4, GOL

Interfaces

1 interface between chains.

  • A–B · 101 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • 4QP5 · Catalytic domain of the antimicrobial peptidase lysostaphin from Staphylococcus simulans… · the same entry in another collection · chain A against A, TM-score 1.00
  • P10547 · AlphaFold monomer V2.0 prediction for lysostaphin (P10547) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.